Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia.

The British journal of psychiatry : the journal of mental science - 1 Jun 2008

Yevtushenko Olga O, Cooper Stephen J, O'Neill Ryan, Doherty Jennifer K, Woodside Jayne V, Reynolds Gavin P

Abstract excerpt

BACKGROUND: Obesity and metabolic syndrome are significant problems for patients taking antipsychotic drugs. Evidence is emerging of genetic risk factors. AIMS: To investigate the influence of two candidate genes, smoking and drug treatment on obesity and metabolic syndrome in patients with schizophrenia. METHOD: Patients (n=134) were assessed for measures of obesity, other factors contributing to metabolic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leptin

Share to Metabolic Syndrome

Share to Obesity

Share to Receptor, Serotonin, 5-HT2C

Share to Schizophrenia

Share to Smoking

Source

Identifiers

PMID: 18515891
DOI: 10.1192/bjp.bp.107.041723

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia.PMID 18515891Read ↗

Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.Semantic proximity Read ↗

Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatmentSemantic proximity Read ↗

Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or ClozapineSemantic proximity Read ↗

Genetic Correlates of Olanzapine-Induced Weight Gain in Schizophrenia Subjects from North India: Role of Metabolic Pathway GenesSemantic proximity Read ↗

Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia.Semantic proximity Read ↗

Pharmacogenetics of Leptin in Antipsychotic-Associated Weight Gain and Obesity-Related ComplicationsSemantic proximity Read ↗

Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical ReviewSemantic proximity Read ↗

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Semantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.Semantic proximity Read ↗

HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With SchizophreniaSemantic proximity Read ↗

Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.